SurModics (SRDX) PT Raised to $55 at Needham & Company
Tweet Send to a Friend
Needham & Company raised its price target on SurModics (NASDAQ: SRDX) to $55.00 (from $46.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
